High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain
Background The insulin-sensitizing phytocannabinoid, Δ(9)-tetrahydrocannabivarin (THCV) can signal partly via G-protein coupled receptor-55 (GPR55 behaving as either an agonist or an antagonist depending on the assay). The cannabinoid receptor type 1 (CB1R) inverse agonist rimonabant is also a GPR55...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2020-08-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/9811.pdf |
| _version_ | 1797419331394469888 |
|---|---|
| author | Edward T. Wargent Malgorzata Kepczynska Mohamed Sghaier Zaibi David C. Hislop Jonathan R.S. Arch Claire J. Stocker |
| author_facet | Edward T. Wargent Malgorzata Kepczynska Mohamed Sghaier Zaibi David C. Hislop Jonathan R.S. Arch Claire J. Stocker |
| author_sort | Edward T. Wargent |
| collection | DOAJ |
| description | Background The insulin-sensitizing phytocannabinoid, Δ(9)-tetrahydrocannabivarin (THCV) can signal partly via G-protein coupled receptor-55 (GPR55 behaving as either an agonist or an antagonist depending on the assay). The cannabinoid receptor type 1 (CB1R) inverse agonist rimonabant is also a GPR55 agonist under some conditions. Previous studies have shown varied effects of deletion of GPR55 on energy balance and glucose homeostasis in mice. The contribution of signalling via GPR55 to the metabolic effects of THCV and rimonabant has been little studied. Methods In a preliminary experiment, energy balance and glucose homeostasis were studied in GPR55 knockout and wild-type mice fed on both standard chow (to 20 weeks of age) and high fat diets (from 6 to 15 weeks of age). In the main experiment, all mice were fed on the high fat diet (from 6 to 14 weeks of age). In addition to replicating the preliminary experiment, the effects of once daily administration of THCV (15 mg kg−1 po) and rimonabant (10 mg kg−1 po) were compared in the two genotypes. Results There was no effect of genotype on absolute body weight or weight gain, body composition measured by either dual-energy X-ray absorptiometry or Nuclear Magnetic Resonance (NMR), fat pad weights, food intake, energy expenditure, locomotor activity, glucose tolerance or insulin tolerance in mice fed on chow. When the mice were fed a high fat diet, there was again no effect of genotype on these various aspects of energy balance. However, in both experiments, glucose tolerance was worse in the knockout than the wild-type mice. Genotype did not affect insulin tolerance in either experiment. Weight loss in rimonabant- and THCV-treated mice was lower in knockout than in wild-type mice, but surprisingly there was no detectable effect of genotype on the effects of the drugs on any aspect of glucose homeostasis after taking into account the effect of genotype in vehicle-treated mice. Conclusions Our two experiments differ from those reported by others in finding impaired glucose tolerance in GPR55 knockout mice in the absence of any effect on body weight, body composition, locomotor activity or energy expenditure. Nor could we detect any effect of genotype on insulin tolerance, so the possibility that GPR55 regulates glucose-stimulated insulin secretion merits further investigation. By contrast with the genotype effect in untreated mice, we found that THCV and rimonabant reduced weight gain, and this effect was in part mediated by GPR55. |
| first_indexed | 2024-03-09T06:46:48Z |
| format | Article |
| id | doaj.art-eb1cde2bc3be4c58837b3e8aa7d74850 |
| institution | Directory Open Access Journal |
| issn | 2167-8359 |
| language | English |
| last_indexed | 2024-03-09T06:46:48Z |
| publishDate | 2020-08-01 |
| publisher | PeerJ Inc. |
| record_format | Article |
| series | PeerJ |
| spelling | doaj.art-eb1cde2bc3be4c58837b3e8aa7d748502023-12-03T10:35:56ZengPeerJ Inc.PeerJ2167-83592020-08-018e981110.7717/peerj.9811High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gainEdward T. Wargent0Malgorzata Kepczynska1Mohamed Sghaier Zaibi2David C. Hislop3Jonathan R.S. Arch4Claire J. Stocker5Institute of Translational Medicine, University of Buckingham, Buckingham, United KingdomMedical School, University of Buckingham, Buckingham, United KingdomInstitute of Translational Medicine, University of Buckingham, Buckingham, United KingdomMedical School, University of Buckingham, Buckingham, United KingdomInstitute of Translational Medicine, University of Buckingham, Buckingham, United KingdomMedical School, University of Buckingham, Buckingham, United KingdomBackground The insulin-sensitizing phytocannabinoid, Δ(9)-tetrahydrocannabivarin (THCV) can signal partly via G-protein coupled receptor-55 (GPR55 behaving as either an agonist or an antagonist depending on the assay). The cannabinoid receptor type 1 (CB1R) inverse agonist rimonabant is also a GPR55 agonist under some conditions. Previous studies have shown varied effects of deletion of GPR55 on energy balance and glucose homeostasis in mice. The contribution of signalling via GPR55 to the metabolic effects of THCV and rimonabant has been little studied. Methods In a preliminary experiment, energy balance and glucose homeostasis were studied in GPR55 knockout and wild-type mice fed on both standard chow (to 20 weeks of age) and high fat diets (from 6 to 15 weeks of age). In the main experiment, all mice were fed on the high fat diet (from 6 to 14 weeks of age). In addition to replicating the preliminary experiment, the effects of once daily administration of THCV (15 mg kg−1 po) and rimonabant (10 mg kg−1 po) were compared in the two genotypes. Results There was no effect of genotype on absolute body weight or weight gain, body composition measured by either dual-energy X-ray absorptiometry or Nuclear Magnetic Resonance (NMR), fat pad weights, food intake, energy expenditure, locomotor activity, glucose tolerance or insulin tolerance in mice fed on chow. When the mice were fed a high fat diet, there was again no effect of genotype on these various aspects of energy balance. However, in both experiments, glucose tolerance was worse in the knockout than the wild-type mice. Genotype did not affect insulin tolerance in either experiment. Weight loss in rimonabant- and THCV-treated mice was lower in knockout than in wild-type mice, but surprisingly there was no detectable effect of genotype on the effects of the drugs on any aspect of glucose homeostasis after taking into account the effect of genotype in vehicle-treated mice. Conclusions Our two experiments differ from those reported by others in finding impaired glucose tolerance in GPR55 knockout mice in the absence of any effect on body weight, body composition, locomotor activity or energy expenditure. Nor could we detect any effect of genotype on insulin tolerance, so the possibility that GPR55 regulates glucose-stimulated insulin secretion merits further investigation. By contrast with the genotype effect in untreated mice, we found that THCV and rimonabant reduced weight gain, and this effect was in part mediated by GPR55.https://peerj.com/articles/9811.pdfGPR55THCVRimonabantDiabetesObesityGlucose tolerance |
| spellingShingle | Edward T. Wargent Malgorzata Kepczynska Mohamed Sghaier Zaibi David C. Hislop Jonathan R.S. Arch Claire J. Stocker High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain PeerJ GPR55 THCV Rimonabant Diabetes Obesity Glucose tolerance |
| title | High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain |
| title_full | High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain |
| title_fullStr | High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain |
| title_full_unstemmed | High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain |
| title_short | High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain |
| title_sort | high fat fed gpr55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or δ 9 tetrahydrocannabivarin on weight gain |
| topic | GPR55 THCV Rimonabant Diabetes Obesity Glucose tolerance |
| url | https://peerj.com/articles/9811.pdf |
| work_keys_str_mv | AT edwardtwargent highfatfedgpr55nullmicedisplayimpairedglucosetolerancewithoutconcomitantchangesinenergybalanceorinsulinsensitivitybutarelessresponsivetotheeffectsofthecannabinoidsrimonabantord9tetrahydrocannabivarinonweightgain AT malgorzatakepczynska highfatfedgpr55nullmicedisplayimpairedglucosetolerancewithoutconcomitantchangesinenergybalanceorinsulinsensitivitybutarelessresponsivetotheeffectsofthecannabinoidsrimonabantord9tetrahydrocannabivarinonweightgain AT mohamedsghaierzaibi highfatfedgpr55nullmicedisplayimpairedglucosetolerancewithoutconcomitantchangesinenergybalanceorinsulinsensitivitybutarelessresponsivetotheeffectsofthecannabinoidsrimonabantord9tetrahydrocannabivarinonweightgain AT davidchislop highfatfedgpr55nullmicedisplayimpairedglucosetolerancewithoutconcomitantchangesinenergybalanceorinsulinsensitivitybutarelessresponsivetotheeffectsofthecannabinoidsrimonabantord9tetrahydrocannabivarinonweightgain AT jonathanrsarch highfatfedgpr55nullmicedisplayimpairedglucosetolerancewithoutconcomitantchangesinenergybalanceorinsulinsensitivitybutarelessresponsivetotheeffectsofthecannabinoidsrimonabantord9tetrahydrocannabivarinonweightgain AT clairejstocker highfatfedgpr55nullmicedisplayimpairedglucosetolerancewithoutconcomitantchangesinenergybalanceorinsulinsensitivitybutarelessresponsivetotheeffectsofthecannabinoidsrimonabantord9tetrahydrocannabivarinonweightgain |